ArticleJournal of medical cases2026
Remimazolam for Procedural Sedation During Computed Tomography Angiography in a Patient With Poor Myocardial Performance Due to Cardiomyopathy.
Article in Journal of medical cases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Given their cognitive and developmental status, sedation is frequently required for procedural imaging in infants and children. Although generally free of adverse effects, the agents used for procedural sedation may impact airway, hemodynamic, and respiratory function, especially in the presence of comorbid cardiac involvement. We present the use of the novel benzodiazepine, remimazolam, administered by continuous infusion and supplemented with intermittent bolus doses of ketamine to provide sedation during computed tomography angiography in a 16-month-old girl, who presented with myocardial dysfunction related to a primary cardiomyopathy. Previous reports of remimazolam administration to patients with underlying comorbid cardiac disease are reviewed, and its applications in this scenario are discussed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.